Population Pharmacokinetics of Apixaban in Subjects With Nonvalvular Atrial Fibrillation

Cirincione, B; Kowalski, K; Nielsen, J; Roy, A; Thanneer, N; Byon, W; Boyd, R; Wang, XL; Leil, T; LaCreta, F; Ueno, T; Oishi, M; Frost, C

Frost, C (reprint author), Bristol Myers Squibb Co, Clin Pharmacol & Pharmacometr, Princeton, NJ 08540 USA.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2018; 7 (11): 728

Abstract

This analysis describes the population pharmacokinetics (PPK) of apixaban in nonvalvular atrial fibrillation (NVAF) subjects, and quantifies the impac......

Full Text Link